ANDA Submissions | Amendments to Abbreviated New Drug Applications Under GDUFA: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 11, 2024
September 16, 2024
9fe16cd4-ef07-4dd1-8241-a762f71acbb7
Related Documents
Requests for Reconsideration at the Division Level Under GDUFA
Guidance DocumentOctober 16, 2024Center for Drug Evaluation and Research
Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA: Guidance for Industry
Guidance DocumentAugust 20, 2024Center for Drug Evaluation and Research
Controlled Correspondence Related to Generic Drug Development
Guidance DocumentMarch 18, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox